GenomeWeb spoke to Aebersold this week from New York to get his thoughts on the meeting and what is happening in the world of proteomics more generally.
CareFirst covers more than 3 million patients in Maryland, Washington DC, and Virginia, and is one several payors to recently issue a coverage decision for Vermillion.
The project combined proteomic, lipidomic, and metabolomic analyses of 174 knockout yeast strains using a high-throughput mass spectrometry workflow.
The company believes its phosphotyrosine enrichment reagents will enable deeper phosphoproteomic studies and aid in drug and diagnostics development.
ImmunArray will use Quanterix's Simoa single-molecule array technology for biomarker analysis, with the potential to enrich its diagnostic panels.
In Nature this week: genetic link between birth weight and adult-onset diseases, and more.
Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.
DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.
Researchers discuss the need for antibody standards at a meeting, NPR reports.